Publications by authors named "Sayaka Hanazawa"

Article Synopsis
  • The study treated 116 advanced/recurrent ovarian cancer patients and 102 uterine cancer patients using hyperthermia and immunotherapy between 2005-2013, after standard therapies were ineffective or declined.
  • 29 (25%) ovarian cancer patients showed clinical benefit, with a combination of therapies achieving a 47.5% effective rate, while uterine cancer patients had a lower benefit rate of 12.7%.
  • The effectiveness varied by cancer type, with cervical cancer, endometrial cancer, and uterine sarcoma having clinical benefit rates of 7.9%, 22.5%, and 12.5%, respectively, highlighting the potential of combined treatments.
View Article and Find Full Text PDF